Literature DB >> 4818161

Recurrence of venous thromboembolic disease and use of oral contraceptives.

M A Badaracco, M P Vessey.   

Abstract

In 1969 this department reported on 42 women who had developed "idiopathic" venous thromboembolism while using oral contraceptives and 42 women who had developed the disease in the absence of such exposure. We have traced the subsequent history of these women to obtain information about recurrence of the disease.During the follow-up period the risk of recurrence of thromboembolism during pregnancy or the puerperium appeared to be much the same irrespective of whether or not oral contraceptives had been in use at the time of the index attack. Recurrences unassociated with childbearing however, occurred about four times more often among women who had not been using oral contraceptives at the time of the index attack than among women who had been doing so. None of these findings was influenced by the use of oral contraceptives during the follow-up period, since exposure to the preparations was negligible after the index attack.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4818161      PMCID: PMC1633083          DOI: 10.1136/bmj.1.5901.215

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  1 in total

1.  Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report.

Authors:  M P Vessey; R Doll
Journal:  Br Med J       Date:  1969-06-14
  1 in total
  15 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.

Authors: 
Journal:  BMJ       Date:  1992-09-05

Review 3.  Anticoagulants in pregnancy.

Authors:  C M Oakley
Journal:  Br Heart J       Date:  1995-08

4.  Anticoagulants.

Authors:  M de Swiet
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

5.  Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities.

Authors:  Mark H Eckman; Pablo Alonso-Coello; Gordon H Guyatt; Shanil Ebrahim; Kari A O Tikkinen; Luciane Cruz Lopes; Ignacio Neumann; Sarah D McDonald; Yuqing Zhang; Qi Zhou; Elie A Akl; Ann Flem Jacobsen; Amparo Santamaría; Joyce Maria Annichino-Bizzacchi; Wael Bitar; Per Morten Sandset; Shannon M Bates
Journal:  Thromb Res       Date:  2015-05-22       Impact factor: 3.944

Review 6.  Hormonal steroid contraceptives: a further review of adverse reactions.

Authors:  E G McQueen
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

7.  Letter: Smoking and deep vein thrombosis.

Authors:  R Doll
Journal:  Br Med J       Date:  1974-08-17

Review 8.  Management of thromboembolism in pregnancy.

Authors:  M de Swiet
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

9.  [Complications and late sequelae of contraception including sterilization (proceedings)].

Authors:  J Hammerstein
Journal:  Arch Gynakol       Date:  1977-07-29

Review 10.  Epidemiology of venous thromboembolism.

Authors:  W W Coon
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.